We attended UBS’s Global Healthcare Conference 2015 from May 18th to May 20th in New York. CEOs and CFOs of roughly 150 companies presented their companies to the investor community followed by question and answer sessions.
Below we reflect on some of our broader sector takeaways from this conference. We left New York more optimistic than ever regarding the future of the healthcare sector, despite a volatile macro environment.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.